Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 4-Bromoaniline | HCID 7807 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-(3-Chloropropyl)-2-methyl-1,3-dioxolane | HCID 80079 | — |
| Reactant | Sodium Methoxide | HCID 10942334 | — |
| Reactant | Butanoyl chloride, 2-oxo- | HCID 11007880 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | Triethylamine | HCID 8471 | — |
| Product | HCID 22566204 | HCID 22566204 | — |
Reaction Steps
Part A: 1-[4-bromophenyl]-4-acetyl-2,3-dioxopiperidine was prepared in four steps in 10% overall yield by the following sequence of reactions. Commercially available 4-bromoaniline was treated with commercially available 5-chloro-2-pentanone ethylene ketal in dimethylformamide in the presence of potassium carbonate for three days. The crude alkylated aniline was treated with ethyloxalyl chloride in THF the presence of triethylamine. Hydrolysis of the ketal was accomplished by treating with aqueous HCl and the resulting material was subjected to Dieckmann cyclization conditions (NaOMe, methanol). The crude dioxopiperidine was purified by flash chromatography (elution with 4:1 hexanes/ethylacetate) to afford the title compound. 1H NMR (dmso d6): δ 7.56 (d, 2H, J =8 Hz), 7.26 (d, 2H, J =8 Hz), 3.60 (t, 2H), 3.28 (t, 2H), 2.30 (s, 3H). LRMS (ES+): 281.0 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06506771B2 |
|---|
| Source dataset | uspto-grants-2003_01 |
|---|
| ORD ID | ord-8af08bcdc464452e9c19f10a6a5fd9d2 |
|---|
| Source note | uspto-grants-2003_01 |
|---|